80 related articles for article (PubMed ID: 7920911)
1. [Comparative study of the in vitro effects of calcitonin, NaF and ipriflavone in cell culture].
Bucsi L; Ashton BA
Magy Traumatol Ortop Kezseb Plasztikai Seb; 1994; 37(3):257-60. PubMed ID: 7920911
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and bone effects after administration of ipriflavone and salmon calcitonin in postmenopausal osteoporosis.
Cecchettin M; Bellometti S; Cremonesi G; Solimeno LP; Torri G
Biomed Pharmacother; 1995; 49(10):465-8. PubMed ID: 8746073
[TBL] [Abstract][Full Text] [Related]
3. Sodium fluoride lacks mitogenic activity for fetal human bone cells in vitro.
Kopp JB; Robey PG
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S137-41. PubMed ID: 2339623
[TBL] [Abstract][Full Text] [Related]
4. Effects of phytoestrogenic isoflavones from red clover (Trifolium pratense L.) on experimental osteoporosis.
Occhiuto F; Pasquale RD; Guglielmo G; Palumbo DR; Zangla G; Samperi S; Renzo A; Circosta C
Phytother Res; 2007 Feb; 21(2):130-4. PubMed ID: 17117453
[TBL] [Abstract][Full Text] [Related]
5. [Expression of proto-oncogenes c-fos and c-jun in osteoblasts activated by excessive fluoride].
Zhang WL; Cui YN; Gao S; Zhang XY; Li GS
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Jul; 37(4):246-50. PubMed ID: 12930673
[TBL] [Abstract][Full Text] [Related]
6. [Direct effects of fluoride on activities of bone morphogenetic protein].
Xu S; Zheng G; Li M; Shu B
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Jul; 34(4):215-7. PubMed ID: 11860933
[TBL] [Abstract][Full Text] [Related]
7. Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopause.
Gennari C; Agnusdei D; Crepaldi G; Isaia G; Mazzuoli G; Ortolani S; Bufalino L; Passeri M
Menopause; 1998; 5(1):9-15. PubMed ID: 9689189
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
[TBL] [Abstract][Full Text] [Related]
9. [Fluoride treatment: a good choice in osteoporosis].
Duursma SA; Raymakers JA
Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1915-9. PubMed ID: 9856178
[TBL] [Abstract][Full Text] [Related]
10. Oral bovine lactoferrin improves bone status of ovariectomized mice.
Blais A; Malet A; Mikogami T; Martin-Rouas C; Tomé D
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1281-8. PubMed ID: 19336659
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cytotoxic activity of sodium fluoride against human periodontal ligament fibroblasts by water pressure.
Chien CH; Otsuki S; Chowdhury SA; Kobayashi M; Takahashi K; Kanda Y; Kunii S; Sakagami H; Kanegae H
In Vivo; 2006; 20(6B):849-56. PubMed ID: 17203778
[TBL] [Abstract][Full Text] [Related]
12. [A new treatment possibility for osteoporosis with osteochin (ipriflavone) tablets].
Bossányi A; Bucsi L
Magy Traumatol Orthop Helyreallito Seb; 1989; 32(2):109-15. PubMed ID: 2570885
[TBL] [Abstract][Full Text] [Related]
13. Molecular physiology and pharmacology of calcitonin.
Huang CL; Sun L; Moonga BS; Zaidi M
Cell Mol Biol (Noisy-le-grand); 2006 Sep; 52(3):33-43. PubMed ID: 17535752
[TBL] [Abstract][Full Text] [Related]
14. [Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis].
Celi M; Letizia C; Ragno A; Minisola S; D'Erasmo E; Mazzuoli GF
Minerva Med; 2002 Dec; 93(6):471-8. PubMed ID: 12515970
[TBL] [Abstract][Full Text] [Related]
15. Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula.
Qin L; Han T; Zhang Q; Cao D; Nian H; Rahman K; Zheng H
J Ethnopharmacol; 2008 Jul; 118(2):271-9. PubMed ID: 18501540
[TBL] [Abstract][Full Text] [Related]
16. Anabolic effects of fluoride on bone.
Pak CY; Zerwekh JE; Antich P
Trends Endocrinol Metab; 1995 Sep; 6(7):229-34. PubMed ID: 11540313
[TBL] [Abstract][Full Text] [Related]
17. Dietary isoflavones act on bone marrow osteoprogenitor cells and stimulate ovary development before influencing bone mass in pre-pubertal piglets.
De Wilde A; Maria Rassi C; Cournot G; Colin C; Lacroix HC; Chaumaz G; Coxam V; Bennetau-Pelissero C; Pointillart A; Lieberherr M
J Cell Physiol; 2007 Jul; 212(1):51-9. PubMed ID: 17348029
[TBL] [Abstract][Full Text] [Related]
18. Studies on the effects of biomedicinal agents on serum concentration of Ca2+, P and ALP activity in osteoporosis-induced rats.
Kim SK; Lee MH; Rhee MH
J Vet Sci; 2003 Aug; 4(2):151-4. PubMed ID: 14610368
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
[TBL] [Abstract][Full Text] [Related]
20. Effects of ipriflavone on caged layer bone metabolism in vitro and in vivo.
Yao J; Zhang J; Hou JF
Poult Sci; 2007 Mar; 86(3):503-7. PubMed ID: 17297162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
